3814-20-8

Basic information

• Product Name: 4-MERCAPTOACETOPHENONE
• Synonyms: 4-MERCAPTOACETOPHENONE;4-Acetylbenzenethiol;4-Acetylthiophenol;3-Chloro-6-dimethylaminopyridazine
• CAS NO: 3814-20-8
• Molecular Formula: C₈H₈OS
• Molecular Weight: 152.21
• Mol File: 3814-20-8.mol

Chemical Properties

• Boiling Point: 307.3°C at 760 mmHg
• Flash Point: 139.7°C
• Appearance: /
• Density: 1.252g/cm³
• Vapor Pressure: 0.000729mmHg at 25°C
• Refractive Index: 1.576
• CAS DataBase Reference: 4-MERCAPTOACETOPHENONE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-MERCAPTOACETOPHENONE(3814-20-8)
• EPA Substance Registry System: 4-MERCAPTOACETOPHENONE(3814-20-8)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 3814-20-8(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Journal of the American Chemical Society, 75, p. 4657, 1953 DOI: 10.1021/ja01115a010

InChI:InChI=1/C6H8ClN3/c1-10(2)6-4-3-5(7)8-9-6/h3-4H,1-2H3

Upstream product

• 1778-09-2 4-(Methylthio)acetophenone 
• 403-42-9 1-(4-fluorophenyl)ethanone 
• 103-04-8 (phenylthio)acetic acid 
• 13329-40-3 4-Iodoacetophenone 
• 99-90-1 para-bromoacetophenone 
• 145388-13-2 3-(3-nitrophenyl)-1-phenyl-3-phenylsulphanylpropan-1-one 
• 13511-90-5 S-4-acetylphenyl N,N-dimethylthiocarbamate 
• 19262-73-8 4-Acetyl-phenyl-diazonium 
• 17067-15-1 (4-acetyl-phenylsulfanyl)-acetic acid 
• 5335-82-0 1,1'-(disulfane-1,2-diylbis(4,1-phenylene))bis(ethan-1-one) 
• 99-92-3 p-aminobenzophenone 
• 128671-32-9 Ethyl (Z)-3-(4-acetylphenylthio)cinnamate 

Downstream Products

• 17067-15-1 (4-acetyl-phenylsulfanyl)-acetic acid 
• 86601-99-2 1-[4-(2,4-dinitro-phenylsulfanyl)-phenyl]-ethanone 
• 41341-56-4 (2R,3R,4S,5R,6S)-2-(acetoxymethyl)-6-[(4-acetylphenyl)thio]tetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 35657-12-6 p-Acetylphenyl-chlormethyl-sulfid 
• 13511-90-5 S-4-acetylphenyl N,N-dimethylthiocarbamate 
• 5335-82-0 1,1'-(disulfane-1,2-diylbis(4,1-phenylene))bis(ethan-1-one) 
• 93008-21-0 1-[4-(4-dimethylamino-phenylsulfanyl)-phenyl]-ethanone 
• 107771-67-5 1-[4-(3-amino-phenylsulfanyl)-phenyl]-ethanone 
• 77069-55-7 1-(4-mercaptophenyl)ethanol 
• 23939-49-3 S-(4-vinylphenyl) thioacetate 
• 108323-50-8 1-(1-acetoxy-ethyl)-4-acetylsulfanyl-benzene 
• 847142-01-2 4-[(2,6-dimethylbenzyl)-thio]acetophenone 
• 869854-63-7 C₁₇H₁₃NOS 
• 10169-55-8 1-[4-(phenylthio)phenyl]ethan-1-one 

Relevant articles and documents

Discovery of 3,5-Dimethyl-4-Sulfonyl-1 H-Pyrrole-Based Myeloid Cell Leukemia 1 Inhibitors with High Affinity, Selectivity, and Oral Bioavailability

Myeloid cell leukemia 1 (Mcl-1) protein is a key negative regulator of apoptosis, and developing Mcl-1 inhibitors has been an attractive strategy for cancer therapy. Herein, we describe the rational design, synthesis, and structure-activity relationship study of 3,5-dimethyl-4-sulfonyl-1H-pyrrole-based compounds as Mcl-1 inhibitors. Stepwise optimizations of hit compound 11 with primary Mcl-1 inhibition (52%@30 μM) led to the discovery of the most potent compound 40 with high affinity (Kd = 0.23 nM) and superior selectivity over other Bcl-2 family proteins (>40,000 folds). Mechanistic studies revealed that 40 could activate the apoptosis signal pathway in an Mcl-1-dependent manner. 40 exhibited favorable physicochemical properties and pharmacokinetic profiles (F% = 41.3%). Furthermore, oral administration of 40 was well tolerated to effectively inhibit tumor growth (T/C = 37.3%) in MV4-11 xenograft models. Collectively, these findings implicate that compound 40 is a promising antitumor agent that deserves further preclinical evaluations.

Expanding the Structural Diversity of Protein Building Blocks with Noncanonical Amino Acids Biosynthesized from Aromatic Thiols

Incorporation of structurally novel noncanonical amino acids (ncAAs) into proteins is valuable for both scientific and biomedical applications. To expand the structural diversity of available ncAAs and to reduce the burden of chemically synthesizing them, we have developed a general and simple biosynthetic method for genetically encoding novel ncAAs into recombinant proteins by feeding cells with economical commercially available or synthetically accessible aromatic thiols. We demonstrate that nearly 50 ncAAs with a diverse array of structures can be biosynthesized from these simple small-molecule precursors by hijacking the cysteine biosynthetic enzymes, and the resulting ncAAs can subsequently be incorporated into proteins via an expanded genetic code. Moreover, we demonstrate that bioorthogonal reactive groups such as aromatic azides and aromatic ketones can be incorporated into green fluorescent protein or a therapeutic antibody with high yields, allowing for subsequent chemical conjugation.

SINGLE-STEP SYNTHESIS METHOD OF ARYL THIOL AND APPLICATION THEREOF

The present invention relates to a single-step synthesis method of aryl thiol, and more specifically, to a method of synthesizing aryl thiol in a single-step by making aryl halide react with alkane dithiol in the presence of a transition metal catalyst. According to the present invention, a single-step synthesis method using the transition metal catalyst, the synthesis method which is capable of synthesizing aryl thiol from aryl halide at a high yield, can be provided. Various aryl halides may be applied to the synthesis method. Further, the synthesis method has advantages that an easily usable reagent may be used, operations are simple, and reactions can be performed under mild conditions. In addition, the synthesized aryl thiol may be used in the synthesis of advanced molecules such as diaryl sulfides and benzothiophenes.COPYRIGHT KIPO 2017

Copper-Catalyzed Direct Synthesis of Aryl Thiols from Aryl Iodides Using Sodium Sulfide Aided by Catalytic 1,2-Ethanedithiol

A copper-catalyzed direct and effective synthesis of aryl thiols from aryl iodides using readily available Na 2 S·9H 2 O and 1,2-ethanedithiol was described. A variety of aryl thiols were readily obtained in yields of 76-99%. In this protocol, Na 2 S·9H 2 O was used as ultimate sulfur source, and 1,2-ethanedithiol functioned as an indispensable catalytic reagent.

Copper(II)-Catalyzed Single-Step Synthesis of Aryl Thiols from Aryl Halides and 1,2-Ethanedithiol

A highly efficient transition metal-catalyzed single-step synthesis of aryl thiols from aryl halides has been developed employing copper(II) catalyst and 1,2-ethanedithiol. The key features are use of readily available reagents, a simple operation, and relatively mild reaction conditions. This new protocol shows a broad substrate scope with excellent functional group compatibility. A variety of aryl thiols are directly prepared from aryl halides in high yields. Furthermore, the aryl thiols are used in situ for the synthesis of more advanced molecules such as diaryl sulfides and benzothiophenes.

Copper-catalyzed coupling of thiourea with aryl iodides: The direct synthesis of aryl thiols

A general, economical and efficient protocol for the direct copper-catalyzed coupling of thiourea with aryl iodides is developed and it will be potentially applied in large-scale industry as a preferred process.

A general and efficient approach to aryl thiols: Cul-catalyzed coupling of aryl iodides with sulfur and subsequent reduction

A Cul-catalyzed coupling reaction of aryl iodides and sulfur powder takes place in the presence of K2CO3 at 90 °C. The coupling mixture is directly treated with NaBH4 or triphenylphosphine to afford aryl thiols in good to

NOVEL INHIBITORS OF HISTONE DEACETYLASE FOR THE TREATMENT OF DISEASE

Disclosed herein are carbonyl compounds of Formula: (I) as described herein. Compounds as modulators of histone deacetylase (HDAC), pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.

Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof

The invention concerns novel substituted 1,3-diphenylprop-2-en-1-one derivatives, pharmaceutical compositions comprising same, their therapeutic uses, in particular for treating cerebral ischemia. The invention also concerns a method for preparing said derivatives.

Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof

The invention concerns compositions comprising substituted 1,3-diphenylprop-2-en-1-one derivatives designed for therapeutic use. The inventive compositions are useful in particular for preventing or treating cardiovascular diseases, syndrome X, la restenosis, diabetes, obesity, hypertension, inflammatory diseases, cancers or neoplasms (benign or malignant tumors), neurodegenerative, dermatological diseases and disorders related to oxidative stress, for preventing or treating the effects of ageing in general and for example skin ageing, in particular in the field of cosmetics (occurrence of wrinkles and the like).